These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8653621)

  • 21. New treatments and azathioprine in multiple sclerosis.
    Kolar OJ
    Lancet; 1997 Oct; 350(9083):1033. PubMed ID: 9329539
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunosuppressive treatment in multiple sclerosis].
    Vermeulen M; Zegerius L; van Crevel H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance of neutralizing antibodies to immunomodulatory therapy and their laboratory analysis in multiple sclerosis].
    Seres E; Vécsei L
    Ideggyogy Sz; 2006 May; 59(5-6):156-62. PubMed ID: 16786710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U; Majeron M; Mascetti A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
    Cendrowski WS
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 105(2):241-6. PubMed ID: 4314087
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppression for multiple sclerosis.
    N Engl J Med; 1983 Jul; 309(4):239-41. PubMed ID: 6866042
    [No Abstract]   [Full Text] [Related]  

  • 27. The limitations of immunosuppressant therapy in Multiple Sclerosis.
    Sedal L
    J Clin Neurosci; 2000 Nov; 7(6):563-4; discussion 564-5. PubMed ID: 11029245
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of prednisone and azathioprine treatment on oligoclonal IGG in the cerebrospinal fluid of multiple sclerosis patients. Preliminary communication].
    Losy J; Karolewska J; Wender M
    Neurol Neurochir Pol; 1996; 30(2):201-11. PubMed ID: 8756247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
    MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis.
    Jeffery DR
    J Neurol Sci; 2004 Aug; 223(1):41-6. PubMed ID: 15261559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The comparison of the effectiveness of treatment of multiple sclerosis relapse with high doses of methylprednisolone, alpha-24 corticotropin and cyclophosphamide].
    Paradowski B; Gruszka E; Pokryszko A
    Pol Merkur Lekarski; 1999 Jun; 6(36):305-7. PubMed ID: 10481540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH; Javed A
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cyclophosphamide therapy in multiple sclerosis].
    Schöffel M; Zschenderlein R; Michalik M
    Psychiatr Neurol Med Psychol (Leipz); 1990 May; 42(5):298-304. PubMed ID: 2201987
    [No Abstract]   [Full Text] [Related]  

  • 34. [Electrophoretic study of the cerebrospinal fluid proteins in multiple sclerosis. II. Influence of immunosuppressive chemotherapy].
    Castaigne P; Lhermitte F; Schuller E; Rouques C; Loridan M
    Rev Eur Etud Clin Biol; 1971; 16(7):703-6. PubMed ID: 4107372
    [No Abstract]   [Full Text] [Related]  

  • 35. [Present possibilities in the therapy of multiple sclerosis].
    Jedlicka P
    Cesk Neurol Neurochir; 1987 Jul; 50(4):209-17. PubMed ID: 2822262
    [No Abstract]   [Full Text] [Related]  

  • 36. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
    Haghikia A; Gold R
    Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pneumocystis carinii pneumonia. Complications of cytotoxic treatment in a systemic vasculitis].
    Gamboa F; Rivera JM; García-Bragado F; Rodríguez Yoldi M
    An Med Interna; 1995 Nov; 12(11):555-6. PubMed ID: 8804172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natalizumab: new drug. Multiple sclerosis: risky market approval.
    Prescrire Int; 2008 Feb; 17(93):7-10. PubMed ID: 18354844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of glatiramer acetate treatment on pre-existing headaches in patients with MS.
    Pöllmann W; Erasmus LP; Feneberg W; Straube A
    Neurology; 2006 Jan; 66(2):275-7. PubMed ID: 16434675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of idiopathic pulmonary fibrosis].
    Dury S
    Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S87-5S91. PubMed ID: 16788517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.